Mercia's Oxford Genetics secures further funds
Technology investor Mercia Fund Management portfolio company Oxford Genetics Ltd, has secured further funds. Oxford Genetics is the biotechnology company behind SnapFast™ - a system that simplifies the purchase of synthetic DNA molecules (plasmids).
30 July 2014•2 mins read
